Biotechnology
News Category
Tonix Pharmaceuticals Reports Q1 2026 Results, Highlights TONMYA Commercial Growth and Pipeline Progress
Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q1 2026 financial results, emphasizing the commercial growth of its newly launched fibromyalgia drug TON...
Lunai Bioworks Sues Alleged Naked Short Sellers for Securities Fraud
Lunai Bioworks filed a federal lawsuit accusing unidentified naked short sellers of manipulating its stock through massive failures to deliver shares,...
Oncotelic Therapeutics Highlighted in BioMedWire Editorial for CNS Drug Delivery Innovation
Oncotelic Therapeutics' proprietary nose-to-brain delivery platform is featured in a BioMedWire editorial, underscoring its potential to overcome the ...
MindBio Therapeutics CEO Discusses AI Voice Detection Platform on TechMediaWire Podcast
MindBio Therapeutics CEO Justin Hanka joins TechMediaWire Podcast to discuss the company's AI-driven voice analysis technology for detecting drug and ...
Oncotelic Therapeutics Advances AI-Powered GMP Manufacturing Platform, Completing Key Phase 2 Objectives
Oncotelic Therapeutics completed Phase 2 objectives of its AI-powered GMP manufacturing platform, advancing commercialization and creating potential o...
GeoVax Highlights Strategic Implications of Gedeptin for Checkpoint-Resistant Cancers
GeoVax Labs discusses the potential of its Gedeptin platform to enhance immune checkpoint inhibitor activity and address checkpoint-resistant tumors, ...
Onco-Innovations Completes AI and Quantum Computing Pilot for PNKP Inhibitor Program
Onco-Innovations Limited announced the successful completion of a pilot project with Kuano Ltd. using AI and quantum computing to advance its PNKP inh...
GeoVax Highlights Gedeptin's Potential in Combination Immunotherapy for Cold Tumors
GeoVax Labs emphasizes Gedeptin's role in overcoming immune resistance and enhancing checkpoint inhibitor efficacy in immunologically cold tumors, wit...
Oncotelic Therapeutics Doses First Patient in Phase 1b Trial of Sapu003 for Advanced Solid Tumors
Oncotelic Therapeutics announced the first patient dosed in a Phase 1b trial of Sapu003, a novel IV formulation of everolimus designed to overcome ora...
SureNano Science's GLP-1 Triple Agonist GEP-44 Targets Next-Generation Obesity Treatment
SureNano Science Ltd., through its subsidiary GlucaPharm, is developing GEP-44, a patented triple agonist peptide targeting GLP-1 and PYY receptors to...
Oncotelic Therapeutics Highlighted in BioMedWire Editorial for CNS Drug Delivery Platform Amid Growing Alzheimer's and Biodefense Demand
Oncotelic Therapeutics is featured in a BioMedWire editorial for its intranasal nose-to-brain delivery platform that bypasses the blood-brain barrier,...
Tonix Pharmaceuticals to Present at Two Investor Conferences in May 2026
Tonix Pharmaceuticals announced its participation in two upcoming investor conferences, highlighting its commercial progress and pipeline developments...
Lantern Pharma Raises $4.4 Million in Registered Direct Offering to Advance AI-Driven Oncology Platform
Lantern Pharma announces a $4.4 million registered direct offering and plans to spin off its AI platform withZeta.ai into an independent entity, signa...
Innovotech Receives NRC IRAP Funding to Advance Antimicrobial Testing Services for Medical Devices
Innovotech Inc. secured up to $234,000 CAD in advisory services and R&D funding from the National Research Council of Canada Industrial Research Assis...
Oncotelic Therapeutics Showcases Nose-to-Brain Drug Delivery Platform in BioMedWire Editorial
Oncotelic Therapeutics' intranasal delivery platform, featured in a BioMedWire editorial, addresses key challenges in CNS drug delivery for Alzheimer'...
Tonix Pharmaceuticals to Present Real-World Fibromyalgia Data at ISPOR 2026
Tonix Pharmaceuticals will present findings from a retrospective cohort study analyzing U.S. claims data on fibromyalgia treatment at ISPOR 2026, foll...
MindBio Therapeutics Highlights AI-Driven Voice Analysis for Intoxication Detection in BioMedWire Editorial
MindBio Therapeutics Corp. is featured in a BioMedWire editorial discussing its AI voice analysis platform that detects impairment from brief speech r...
CNS Pharmaceuticals Reports First-Quarter 2026 Results, Advances Strategic Transformation Toward Acquisition-Driven Growth
CNS Pharmaceuticals is shifting to an acquisition-driven model in neurology and oncology, bolstered by a $22.5 million private placement, while explor...
Kairos Pharma Wins 2026 Healthcare Innovation Award for Drug Resistance Research
Kairos Pharma received the 2026 GHP Magazine Healthcare & Pharmaceutical Award for its work on drug resistance in cancer therapy, highlighting its lea...
SureNano Science's GLP-1 Innovation Highlights Next-Generation Obesity and Diabetes Treatments
SureNano Science Ltd. is featured in a BioMedWire editorial for its subsidiary GlucaPharm's development of GEP-44, a novel triple agonist peptide aimi...
GeoVax Reports First Quarter 2026 Financial Results and Provides Update on GEO-MVA Phase 3 Trial Plans
GeoVax advances GEO-MVA toward a Phase 3 immunobridging study under an EMA-aligned expedited pathway, aiming to address global orthopoxvirus vaccine s...
NanoViricides Advances NV-387 Toward Phase II Trials for MPox and Other Viral Diseases
NanoViricides reported progress on its broad-spectrum antiviral NV-387, including regulatory approval for Phase II MPox trials in the DRC and FDA orph...
MindBio Therapeutics Explores AI-Powered Voice Analysis for Noninvasive Intoxication Detection
MindBio Therapeutics Corp. is advancing AI-driven voice analysis technology to detect drug and alcohol intoxication in real-time, with potential appli...
Annovis Bio Reports First-Quarter Progress in Phase 3 Alzheimer's and Parkinson's Trials
Annovis Bio announced 85% enrollment in its pivotal Phase 3 Alzheimer's trial and 40% enrollment in its Parkinson's open-label extension study, advanc...
Oncotelic Therapeutics Highlights CNS Drug Delivery Innovation in NetworkNewsAudio Editorial
The article discusses Oncotelic Therapeutics' featured editorial on CNS drug delivery challenges and its strategic monetization agreement with Lunai B...
Oncotelic Therapeutics Reports First-Quarter Results, Highlights Progress Across Biotech Platform
Oncotelic Therapeutics announced Q1 2026 financial results and a corporate update, emphasizing advancements in oncology, AI-enabled drug development, ...
SureNano Science's GEP-44 Shows Promise in Next-Generation GLP-1 Therapy Market
SureNano Science Ltd. is advancing GEP-44, a triple agonist peptide targeting obesity and metabolic disorders, with preclinical data suggesting improv...
Humacyte Prices $50 Million Public Offering to Fund Symvess Commercialization and Pipeline Development
Humacyte announced a $50 million public offering of 47.6 million shares at $1.05 each, with proceeds earmarked for Symvess commercialization, a hemodi...
Oragenics Advances Phase IIa Trial for Concussion Treatment, Eyes CNS Device Licensing
Oragenics reported progress in its Phase IIa trial of ONP-002 for concussion in Australia, plans for U.S. regulatory steps, and a letter of intent to ...
Sino Biological Launches XPressMAX™ Kit to Accelerate AI-Powered Antibody Discovery
Sino Biological's new cell-free protein synthesis kit enables ultra-fast antibody production in 3 hours, integrating with AI-driven high-throughput sc...
GeoVax Raises $3 Million in Private Placement to Advance Vaccine and Immunotherapy Pipeline
GeoVax Labs secures $3 million from institutional investors through a private placement priced at-the-market, providing working capital to support its...
GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious Disease Threats
GeoVax emphasizes the need for scalable domestic vaccine manufacturing and diversified supply as WHO declares Ebola emergency and mpox spreads, reinfo...
CEL-SCI Corporation Closes $7.2 Million Public Offering to Advance Multikine Development
CEL-SCI Corporation has closed a $7.2 million public offering, with net proceeds earmarked for the continued development of its lead immunotherapy can...
Oragenics to Present at Sidoti Micro-Cap Virtual Investor Conference
Oragenics Inc. announced its participation in the Sidoti Micro-Cap Virtual Investor Conference, highlighting its lead candidate for concussion treatme...
Oncotelic Therapeutics Expands Beyond Biotech with AI-Enhanced Robotics Strategy
Oncotelic Therapeutics is pivoting from clinical-stage biotech into AI and industrial automation through a strategic partnership with TechForce Roboti...
Quantum BioPharma Reaches Midpoint Enrollment in MS Imaging Study with Massachusetts General Hospital
Quantum BioPharma announced that patient enrollment in its collaborative MS imaging study with Massachusetts General Hospital has reached 50%, with pr...
MindBio Therapeutics Pioneers AI Voice-Based Impairment Detection for Workplace Safety
MindBio Therapeutics is introducing a first-of-its-kind voice-based AI system to detect drug and alcohol impairment, starting with the South American ...
Scinai Immunotherapeutics Appoints Eilon Elmalem as Head of Yavne CDMO Facility, Signaling Expansion of Contract Manufacturing Platform
Scinai Immunotherapeutics Ltd. has appointed Eilon Elmalem as site head of its Yavne CDMO facility, bringing over 20 years of biotech operations exper...
Annovis Bio Prices $15 Million Public Offering to Fund Alzheimer’s and Parkinson’s Trials
Annovis Bio announced a $15 million public offering of common stock and warrants, with proceeds aimed at advancing clinical development of buntanetap ...
Cardio Diagnostics CEO Outlines Precision Medicine Strategy and India Expansion in BioMedWire Podcast
Cardio Diagnostics Holdings (NASDAQ: CDIO) CEO Dr. Meesha Dogan discusses the company's AI-driven precision cardiovascular medicine, its expansion int...
GeoVax Highlights MVA Platform's Potential Amid Bundibugyo Ebola Outbreak
GeoVax comments on the Bundibugyo Ebola outbreak, emphasizing the need for flexible vaccine platforms like its MVA-based technology to address emergin...
Sunshine Biopharma Closes $6 Million Public Offering to Fund Operations and Drug Development
Sunshine Biopharma completed a $6 million public offering, with proceeds earmarked for corporate purposes and working capital, while advancing its gen...
MindBio Therapeutics Expands AI Voice Platform with Fatigue Detection Module
MindBio Therapeutics is expanding its AI voice analytics platform to include fatigue detection alongside drug and alcohol impairment screening, target...
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection
HeartBeam is developing a portable, cable-free ECG platform that generates synthesized 12-lead signals from multidirectional recordings, aiming to add...
GeoVax Prioritizes GEO-MVA and Gedeptin Programs, Discontinues COVID-19 Vaccine Development
GeoVax Labs refocuses its portfolio on GEO-MVA for mpox/smallpox and oncology candidate Gedeptin, discontinuing its COVID-19 vaccine due to market con...
Tonix Pharmaceuticals Presents Real-World Data Highlighting High Burden of Fibromyalgia at ISPOR 2026
Tonix Pharmaceuticals presented real-world claims analysis at ISPOR 2026 showing that fibromyalgia patients have high comorbidity rates and substantia...
Onco-Innovations Advances Manufacturing Scale-Up for Lead Oncology Candidate ONC010
Onco-Innovations announced progress in intermediate-scale manufacturing and process development for ONC010's precursor components, supporting IND-enab...
Annovis Bio Regains Compliance with NYSE Listing Standards
Annovis Bio announced it has regained compliance with NYSE continued listing standards after restoring its market capitalization and stockholders' equ...